BIO-TECHNE Corp Net Income
BIO-TECHNE Corp (TECH) reported Net Income of $51.05 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-05-06
- BIO-TECHNE Corp net income (loss) attributable to parent for the quarter ending 2026-03-31 was $51.05M, a 125.99% increase year-over-year.
- BIO-TECHNE Corp net income (loss) attributable to parent for the quarter ending 2025-12-31 was $38.01M, a 8.94% increase year-over-year.
- BIO-TECHNE Corp net income (loss) attributable to parent for the quarter ending 2025-09-30 was $38.19M, a 13.65% increase year-over-year.
- BIO-TECHNE Corp net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$17.68M, a 143.55% decline year-over-year.
- BIO-TECHNE Corp net income (loss) attributable to parent for fiscal 2025 was $73.40M, a 56.34% decline from fiscal 2024.
- BIO-TECHNE Corp net income (loss) attributable to parent for fiscal 2024 was $168.10M, a 41.07% decline from fiscal 2023.
- BIO-TECHNE Corp net income (loss) attributable to parent for fiscal 2023 was $285.26M, a 4.86% increase from fiscal 2022.
- BIO-TECHNE Corp net income (loss) attributable to parent for fiscal 2022 was $272.05M, a 93.75% increase from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $51.05M 10-Q · filed 2026-05-06 | $89.06M derived: sum of 2 quarters · filed 2026-05-06 | $127.24M 10-Q · filed 2026-05-06 | $109.56M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2025-12-31 | $38.01M 10-Q · filed 2026-02-04 | $76.19M 10-Q · filed 2026-02-04 | $58.52M derived: sum of 3 quarters · filed 2026-02-04 | $81.10M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2025-09-30 | $38.19M 10-Q · filed 2025-11-05 | $20.51M derived: sum of 2 quarters · filed 2025-11-05 | $43.09M derived: sum of 3 quarters · filed 2026-05-06 | $77.98M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2025-06-30 | -$17.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $4.91M derived: sum of 2 quarters · filed 2026-05-06 | $39.80M derived: sum of 3 quarters · filed 2026-05-06 | $73.40M 10-K · filed 2025-08-22 | |||
| 2025-03-31 | $22.59M 10-Q · filed 2026-05-06 | $57.48M derived: sum of 2 quarters · filed 2026-05-06 | $91.08M 10-Q · filed 2026-05-06 | $131.67M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $34.89M 10-Q · filed 2026-02-04 | $68.49M 10-Q · filed 2026-02-04 | $109.08M derived: sum of 3 quarters · filed 2026-02-04 | $158.14M derived: sum of 4 quarters · filed 2026-02-04 | |||
| 2024-09-30 | $33.60M 10-Q · filed 2025-11-05 | $74.19M derived: sum of 2 quarters · filed 2025-11-05 | $123.25M derived: sum of 3 quarters · filed 2025-11-05 | $150.71M derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | $40.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $89.65M derived: sum of 2 quarters · filed 2025-08-22 | $117.11M derived: sum of 3 quarters · filed 2025-08-22 | $168.10M 10-K · filed 2025-08-22 | |||
| 2024-03-31 | $49.06M 10-Q · filed 2025-05-08 | $76.52M derived: sum of 2 quarters · filed 2025-05-08 | $127.52M 10-Q · filed 2025-05-08 | $203.00M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-12-31 | $27.46M 10-Q · filed 2025-02-06 | $78.46M 10-Q · filed 2025-02-06 | $153.94M derived: sum of 3 quarters · filed 2025-08-22 | $224.16M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-09-30 | $50.99M 10-Q · filed 2024-11-05 | $126.48M derived: sum of 2 quarters · filed 2025-08-22 | $196.69M derived: sum of 3 quarters · filed 2025-08-22 | $246.70M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-06-30 | $75.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $145.70M derived: sum of 2 quarters · filed 2025-08-22 | $195.71M derived: sum of 3 quarters · filed 2025-08-22 | $285.26M 10-K · filed 2025-08-22 | |||
| 2023-03-31 | $70.22M 10-Q · filed 2024-05-06 | $120.22M derived: sum of 2 quarters · filed 2024-05-06 | $209.78M 10-Q · filed 2024-05-06 | $271.30M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-12-31 | $50.01M 10-Q · filed 2024-02-07 | $139.56M 10-Q · filed 2024-02-07 | $201.08M derived: sum of 3 quarters · filed 2024-08-22 | $261.82M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-09-30 | $89.56M 10-Q · filed 2023-11-07 | $151.08M derived: sum of 2 quarters · filed 2024-08-22 | $211.82M derived: sum of 3 quarters · filed 2024-08-22 | $291.99M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-06-30 | $61.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $122.26M derived: sum of 2 quarters · filed 2024-08-22 | $202.44M derived: sum of 3 quarters · filed 2024-08-22 | $272.05M 10-K · filed 2024-08-22 | |||
| 2022-03-31 | $60.74M 10-Q · filed 2023-05-08 | $140.91M derived: sum of 2 quarters · filed 2023-05-08 | $210.53M 10-Q · filed 2023-05-08 | $225.49M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-12-31 | $80.17M 10-Q · filed 2023-02-07 | $149.79M 10-Q · filed 2023-02-07 | $164.75M derived: sum of 3 quarters · filed 2023-08-23 | $210.53M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-09-30 | $69.61M 10-Q · filed 2022-11-07 | $84.58M derived: sum of 2 quarters · filed 2023-08-23 | $130.36M derived: sum of 3 quarters · filed 2023-08-23 | $176.63M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-06-30 | $14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $60.74M derived: sum of 2 quarters · filed 2023-08-23 | $107.02M derived: sum of 3 quarters · filed 2023-08-23 | $140.41M 10-K · filed 2023-08-23 | |||
| 2021-03-31 | $45.78M 10-Q · filed 2022-05-09 | $92.06M derived: sum of 2 quarters · filed 2022-05-09 | $125.45M 10-Q · filed 2022-05-09 | $184.30M derived: sum of 4 quarters · filed 2022-05-09 | |||
| 2020-12-31 | $46.27M 10-Q · filed 2022-02-07 | $79.67M 10-Q · filed 2022-02-07 | $138.52M derived: sum of 3 quarters · filed 2022-02-07 | $174.95M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-09-30 | $33.40M 10-Q · filed 2021-11-08 | $33.40M 10-Q · filed 2020-11-09 | $128.67M derived: sum of 3 quarters · filed 2021-11-08 | $248.30M derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | $58.85M 10-K · filed 2020-08-26 | $95.28M derived: sum of 2 quarters · filed 2021-05-07 | $214.90M derived: sum of 3 quarters · filed 2021-05-07 | $229.30M 10-K · filed 2022-08-24 | |||
| 2020-03-31 | $36.43M 10-Q · filed 2021-05-07 | $156.05M derived: sum of 2 quarters · filed 2021-05-07 | $170.45M 10-Q · filed 2021-05-07 | $186.91M derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | $119.62M 10-Q · filed 2021-02-08 | $134.02M 10-Q · filed 2021-02-08 | $150.48M derived: sum of 3 quarters · filed 2021-02-08 | $195.13M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-09-30 | $14.40M 10-Q · filed 2021-02-08 | $14.40M 10-Q · filed 2020-11-09 | $75.51M derived: sum of 3 quarters · filed 2021-02-08 | $93.07M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-06-30 | $16.46M 10-K · filed 2020-08-26 | $61.11M derived: sum of 2 quarters · filed 2020-08-26 | $78.67M derived: sum of 3 quarters · filed 2020-08-26 | $96.07M 10-K · filed 2021-08-25 | |||
| 2019-03-31 | $44.65M 10-K · filed 2020-08-26 | $62.21M derived: sum of 2 quarters · filed 2020-08-26 | $79.61M 10-Q · filed 2020-05-11 | $121.31M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-12-31 | $17.56M 10-K · filed 2020-08-26 | $34.96M 10-Q · filed 2020-02-06 | $76.66M derived: sum of 3 quarters · filed 2020-08-26 | $96.40M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-09-30 | $17.40M 10-K · filed 2020-08-26 | $59.10M derived: sum of 2 quarters · filed 2020-08-26 | $78.84M derived: sum of 3 quarters · filed 2020-08-26 | $127.69M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-06-30 | $41.70M 10-K/A · filed 2019-11-06 | $61.44M derived: sum of 2 quarters · filed 2019-11-06 | $110.29M derived: sum of 3 quarters · filed 2019-11-06 | $126.15M 10-K · filed 2020-08-26 | |||
| 2018-03-31 | $19.74M 10-K/A · filed 2019-11-06 | $68.58M derived: sum of 2 quarters · filed 2019-11-06 | $84.45M 10-Q · filed 2019-05-07 | $112.06M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-12-31 | $48.85M 10-K/A · filed 2019-11-06 | $64.71M 10-Q · filed 2019-02-07 | $92.32M derived: sum of 3 quarters · filed 2019-11-06 | $114.49M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-09-30 | $15.86M 10-K/A · filed 2019-11-06 | $43.47M derived: sum of 2 quarters · filed 2019-11-06 | $15.86M 10-Q · filed 2017-11-09 | $73.11M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-06-30 | $27.61M 10-K · filed 2018-08-27 | $49.78M derived: sum of 2 quarters · filed 2018-08-27 | $57.24M derived: sum of 3 quarters · filed 2018-08-27 | $76.09M 10-K/A · filed 2019-11-06 | |||
| 2017-03-31 | $22.17M 10-K · filed 2018-08-27 | $21.39M 10-Q · filed 2017-05-10 | $29.63M derived: sum of 2 quarters · filed 2018-08-27 | $48.48M 10-Q · filed 2018-05-09 | $43.98M 10-Q · filed 2017-05-10 | $74.10M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-12-31 | $7.47M 10-K · filed 2018-08-27 | $6.31M 10-Q · filed 2017-02-09 | $26.31M 10-Q · filed 2018-02-08 | $22.59M 10-Q · filed 2017-02-09 | $51.94M derived: sum of 3 quarters · filed 2018-08-27 | $82.23M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2016-09-30 | $18.84M 10-K · filed 2018-08-27 | $16.28M 10-Q · filed 2016-11-09 | $44.47M derived: sum of 2 quarters · filed 2018-08-27 | $18.84M 10-Q · filed 2017-11-09 | $100.61M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | $25.63M 10-K · filed 2017-09-07 | $55.92M derived: sum of 2 quarters · filed 2017-09-07 | $81.77M derived: sum of 3 quarters · filed 2017-09-07 | $104.48M 10-K · filed 2018-08-27 | |||
| 2016-03-31 | $30.29M 10-K · filed 2017-09-07 | $56.14M derived: sum of 2 quarters · filed 2017-09-07 | $78.85M 10-Q · filed 2017-05-10 | $105.18M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-12-31 | $25.85M 10-K · filed 2017-09-07 | $48.56M 10-Q · filed 2017-02-09 | $74.89M derived: sum of 3 quarters · filed 2017-09-07 | $99.18M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-09-30 | $22.71M 10-K · filed 2017-09-07 | $49.04M derived: sum of 2 quarters · filed 2017-09-07 | $73.33M derived: sum of 3 quarters · filed 2017-09-07 | $106.53M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-06-30 | $26.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $50.62M derived: sum of 2 quarters · filed 2017-09-07 | $83.83M derived: sum of 3 quarters · filed 2017-09-07 | $107.73M 10-K · filed 2017-09-07 | |||
| 2015-03-31 | $24.29M 10-Q · filed 2016-05-10 | $57.50M derived: sum of 2 quarters · filed 2016-05-10 | $81.41M 10-Q · filed 2016-05-10 | $108.23M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-12-31 | $33.21M 10-Q · filed 2016-02-09 | $57.12M 10-Q · filed 2016-02-09 | $83.94M derived: sum of 3 quarters · filed 2016-08-29 | $115.58M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-09-30 | $23.91M 10-Q · filed 2015-11-09 | $50.73M derived: sum of 2 quarters · filed 2016-08-29 | $82.37M derived: sum of 3 quarters · filed 2016-08-29 | $107.43M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-06-30 | $26.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $58.47M derived: sum of 2 quarters · filed 2016-08-29 | $83.52M derived: sum of 3 quarters · filed 2016-08-29 | $110.95M 10-K · filed 2016-08-29 | |||
| 2014-03-31 | $31.64M 10-Q · filed 2015-05-11 | $56.70M derived: sum of 2 quarters · filed 2015-05-11 | $84.12M 10-Q · filed 2015-05-11 | $112.53M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-12-31 | $25.05M 10-Q · filed 2015-02-09 | $52.48M 10-Q · filed 2015-02-09 | $80.89M derived: sum of 3 quarters · filed 2015-08-31 | $114.01M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-09-30 | $27.43M 10-Q · filed 2014-11-10 | $55.84M derived: sum of 2 quarters · filed 2015-08-31 | $88.96M derived: sum of 3 quarters · filed 2015-08-31 | $114.32M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-06-30 | $28.41M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $61.53M derived: sum of 2 quarters · filed 2015-08-31 | $86.89M derived: sum of 3 quarters · filed 2015-08-31 | $112.56M 10-K · filed 2015-08-31 | |||
| 2013-03-31 | $33.12M 10-Q · filed 2014-05-12 | $58.48M derived: sum of 2 quarters · filed 2014-05-12 | $84.15M 10-Q · filed 2014-05-12 | $111.39M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-12-31 | $25.36M 10-Q · filed 2014-02-04 | $51.03M 10-Q · filed 2014-02-04 | $78.27M derived: sum of 3 quarters · filed 2014-08-29 | $110.03M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-09-30 | $25.67M 10-Q · filed 2013-11-12 | $52.91M derived: sum of 2 quarters · filed 2014-08-29 | $84.67M derived: sum of 3 quarters · filed 2014-08-29 | $110.48M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-06-30 | $27.24M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $59.00M derived: sum of 2 quarters · filed 2014-08-29 | $84.81M derived: sum of 3 quarters · filed 2014-08-29 | $112.33M 10-K · filed 2014-08-29 | |||
| 2012-03-31 | $31.76M 10-Q · filed 2013-05-10 | $57.57M derived: sum of 2 quarters · filed 2013-05-10 | $85.09M 10-Q · filed 2013-05-10 | $113.42M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-12-31 | $25.81M 10-Q · filed 2013-02-11 | $53.33M 10-Q · filed 2013-02-11 | $81.67M derived: sum of 3 quarters · filed 2013-08-29 | $112.73M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-09-30 | $27.52M 10-Q · filed 2012-11-09 | $55.85M derived: sum of 2 quarters · filed 2013-08-29 | $86.92M derived: sum of 3 quarters · filed 2013-08-29 | $113.45M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-06-30 | $28.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $59.40M derived: sum of 2 quarters · filed 2013-08-29 | $85.93M derived: sum of 3 quarters · filed 2013-08-29 | $112.30M 10-K · filed 2013-08-29 | |||
| 2011-03-31 | $31.06M 10-Q · filed 2012-05-10 | $57.60M derived: sum of 2 quarters · filed 2012-05-10 | $83.97M 10-Q · filed 2012-05-10 | $109.87M derived: sum of 4 quarters · filed 2012-08-29 | |||
| 2010-12-31 | $26.53M 10-Q · filed 2012-02-07 | $52.91M 10-Q · filed 2012-02-07 | $78.80M derived: sum of 3 quarters · filed 2012-08-29 | $111.19M derived: sum of 4 quarters · filed 2012-08-29 | |||
| 2010-09-30 | $26.37M 10-Q · filed 2011-11-09 | $52.27M derived: sum of 2 quarters · filed 2012-08-29 | $84.66M derived: sum of 3 quarters · filed 2012-08-29 | $109.38M derived: sum of 4 quarters · filed 2012-08-29 | |||
| 2010-06-30 | $25.89M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $58.28M derived: sum of 2 quarters · filed 2012-08-29 | $83.00M derived: sum of 3 quarters · filed 2012-08-29 | $109.78M 10-K · filed 2012-08-29 | |||
| 2010-03-31 | $32.39M 10-Q · filed 2011-05-10 | $57.11M derived: sum of 2 quarters · filed 2011-05-10 | $83.88M 10-Q · filed 2011-05-10 | ||||
| 2009-12-31 | $24.72M 10-Q · filed 2011-02-09 | $51.49M 10-Q · filed 2011-02-09 | |||||
| 2009-09-30 | $26.77M 10-Q · filed 2010-11-09 | ||||||
| 2009-06-30 | $105.24M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |